Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 day ago Contract notice

Poland - General anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents - Supply of medicinal products

Original Polska - Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne - Dostawy produktów leczniczych

Open Poland Małopolskie Medical equipment & pharmaceuticals

Buyer Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

28 days left

Key facts

Closes
08:00 (UTC+1)
Estimated value
€539,812
converted from PLN
Competition
Open race
  1. Published
  2. Today
  3. Deadline open for 38 days
  4. Awarded pending

Bidding window

38 days from publication to deadline

Longer than usual

Notices of this kind (Poland, open procedure, above the EU threshold) give a median of 28 days, half of them between 13 and 33 days, based on 82,475 notices of the last two years.

This buyer usually gives 34 days (median of its last 54 calls for tender).

View the official notice Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

The Aperlena Verdict

Open race

No supplier dominates: 32 different companies have won the last 33 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 33 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

Procurement of medicinal products for drug programmes, divided into 16 lots. The contract covers anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents. Each lot corresponds to one active substance or group: tegoprazine fumarate (tegemil fumarate), various medicinal products, dimethyl fumarate, peginterferon beta-1a, teriflunomide, ofatumumab, ozanimod, ponesimod, siponimod, fingolimod, natalizumab, ocrelizumab, cladribine, alemtuzumab, interferon beta-1b and ublituximab. Bidders may offer one or more lots of the supply contract.

Description

Przedmiot zamówienia obejmuje 16 części- Programy lekowe Część nr 1: Fumaran tegomilu Część nr 2: Różne produkty lecznicze Część nr 3: Fumaran dimetylu Część nr 4: Peginterferon-β-1a Część nr 5: Teryflunomid Część nr 6: Ofatumumab Część nr 7: Ozanimod Część nr 8: Ponesimod Część nr 9: Siponimod Część nr 10: Fingolimod Część nr 11: Natalizumab Część nr 12: Okrelizumab Część nr 13: Kladrybina Część nr 14: Alemtuzumabum Część nr 15: Interferon β- 1b Część nr 16: Ublituksymab Fumaran tegomilu; Różne produkty lecznicze; Fumaran dimetylu; Peginterferon-β-1a; Teryflunomid; Ofatumumab; Ozanimod; Ponesimod; Siponimod; Fingolimod; Natalizumab; Okrelizumab; Kladrybina; Alemtuzumabum; Interferon β- 1b; Ublituksymab

16 lots

Lot 1
Część nr 1: Fumaran tegomilu estimated €6,811 · 12 months
Lot 2
Część nr 2: Różne produkty lecznicze estimated €30,628 · 13 months
Lot 3
Część nr 3: Fumaran dimetylu estimated €6,274 · 12 months
Lot 4
Część nr 4: Peginterferon-β-1a estimated €6,672 · 12 months
Lot 5
Część nr 5: Teryflunomid estimated €307 · 12 months
Lot 6
Część nr 6: Ofatumumab estimated €105,902 · 12 months
Lot 7
Część nr 7: Ozanimod estimated €7,620 · 12 months
Lot 8
Część nr 8: Ponesimod estimated €3,355 · 12 months
How tenders are scored
cena: 100 percent
Show 8 more lots
Lot 9
Część nr 9: Siponimod estimated €11,272 · 12 months
Lot 10
Część nr 10: Fingolimod estimated €113 · 12 months
Lot 11
Część nr 11: Natalizumab estimated €104,413 · 13 months
Lot 12
Część nr 12: Okrelizumab estimated €151,526 · 12 months
Lot 13
Część nr 13: Kladrybina estimated €5,575 · 12 months
Lot 14
Część nr 14: Alemtuzumabum estimated €12,801 · 12 months
Lot 15
Część nr 15: Interferon β- 1b estimated €37,326 · 12 months
Lot 16
Część nr 16: Ublituksymab estimated €8,092 · 12 months

As the official notice states them.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    Estimated at €539,812.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    28 days left, 21 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    This buyer usually awards this kind of contract for between €337,547 and €2.1M.

    Contracts here close a median of 0.2% above their estimate.

  6. In your favour:

    Do we know this buyer?

    32 different companies won the last 33 comparable contracts.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Polish.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

Expected award price

likely award for this notice, from its published estimate of €539,812
€588,395 to €663,969

This buyer's comparable awards in this sector came in at a median of 111% of their published estimate, half of them between 109% and 123%, based on 11 awards of the last 3 years.

Each award is compared with the estimate of the same lots, framework agreements excluded. A published estimate may include options and renewals, so an award under it is not always a discount.

What this buyer has paid before

Based on 74 comparable contracts this buyer awarded in this sector over the last 4 years.

This notice
€539,812
Median award
€962,984
Middle half of past awards
€337,547 to €2.1M

The estimate sits inside the usual range.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Poland

notices in the register
164
awards
105
awarded in total
€985.3M

Who wins its contracts

Many suppliers
different companies won its awards
42
of the awards went to the three most frequent winners
11%
of its calls state an estimated value
89%

Based on 44 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
2.2
of those lots received a single tender
53%
of the awards went to companies based in another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Who usually wins this buyer's contracts in this sector

Based on 33 awards with a linked company profile over the last 5 years.

5 open tenders right now

Market context

Larger than 60% of the open notices in Medical equipment & pharmaceuticals across Europe.

open now in Medical equipment & pharmaceuticals
8,192
median open notice
€303,562

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,373
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,462

Based on 22,919 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

3

days left

Supply of vaccines

Poland Medical equipment & pharmaceuticals Samodzielny Publiczny Zespół Zakładów Lecznictwa Otwartego W...

Awarded before

Never miss a tender like this

976 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: an email when new tenders arrive under it, no account needed.

28 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language